Dec
19
2025
Syremis Therapeutics Launches with $165M to Develop Best-in-Class Medicines for Mental Health Conditions
Addressing major unmet needs in mental health with pharmacology rooted in emerging and clinically validated neuropsychiatric biology * Lead progra …
